Global Disruptive Behavior Disorder Market Size, Trends, and Analysis- Forecasts To 2026 By Type (Oppositional Defiant Disorder, Conduct Disorder, Intermittent Explosive Disorder), By Treatment (Medication Management, Comprehensive Evaluation, Parenting Therapy, Group Therapy, Individual Therapy), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User Landscape, Company Market Share Analysis & Competitor Analysis
The disruptive behavior disorder market is estimated to be around USD 18.5 billion in 2021 and is projected to reach USD 24.5 billion by 2026, at a CAGR of 5.2%.
Factors like rising prevalence of disruptive behavior disorders, growing cases of substance abuses, advancements in treatment plans, increasing disposable income for healthcare services in developing regions, growing teenage patient population, increasing adoption of smart medical technology in healthcare devices, rising new product launch strategy, are supporting the market growth. Moreover, implementation of stringent government rules, and regulations for early disorder diagnosis and treatment management, improved quality of care of developed countries like US and Germany, increasing awareness about the disorder and the treatment of disruptive behavior disorder, availability of a diversity of applications, increasing investments, availability of effective treatment, extensive research and development activities, active involvement of NGO’s for better treatment facilities, rising funding for research, genetic, physical and environmental components, are some of the other drivers of the market that are helping it to grow exponentially.
Disruptive behavior disorders are a group of childhood disorders in which children have difficulty in forming peer connections and develop social skills. As per a survey conducted by WHO, around 3-4% of the population of children have some type of disruptive behavior disorder. Attention deficit hyperactivity disorder, conduct disorder, or oppositional defiant disorder are some of the prime examples of disruptive behaviour disorders. These disorders are increasingly recognized as very real and very serious mental health matters that require professional treatment to get under control. Increased awareness through campaigns about the benefits of disruptive behavior disorder treatment is expected to increase demand for the disruptive behavior disorder market.
According to the type segment, the three categories include oppositional defiant disorder, conduct disorder, and intermittent explosive disorder. The category of oppositional defiant disorder is analyzed to be the largest shareholder from the timeline of 2021 to 2026. Oppositional defiant disorder (ODD) is a condition in which a child exhibits a pattern of uncooperative, defiant, angry, and bothersome conduct toward those in authority that interferes with the kid's ability to function normally. It has the largest share in the market due to the factors such as higher efficacy and efficiency, better diagnosis, non-invasive treatment procedure, light on pocket treatment plan, increasing prevalence of the oppositional defiant disorder, high awareness regarding patient’s condition across the healthcare industry, faster response time and turnaround time, availability of computational support, availability of a diversity of applications, lower sensitivity, and specificity, rising teenage patient population, reliance on the substantial number of approved diagnostic products, wide availability, and accessibility.
According to the treatment analysis, the five segments are medication management, comprehensive evaluation, parenting therapy, group therapy, and individual therapy. In 2020, the medication management segment is predicted to be the largest shareholder in terms of revenue growth in the market mainly due to the effectiveness of the treatment, higher reliability, improved patient satisfaction, improvised quality of care, an increasing number of patients, and improved access to health services, personalized therapy, technologically advanced devices. Furthermore, other factors influencing the segment growth are the rising level of venture funding, improved outcomes, availability of diverse applications, lack of awareness regarding the symptoms of the disorder, increased patient engagement, higher utilization of technology, and early management of health conditions. However, the group therapy segment will be growing the fastest in the market due to factors such as shorter procedure time, enhanced patient’s comfort, and safety, promotion of social skills, faster response time, and improved management & monitoring. Moreover, factors such as development of self-awareness among the individuals, availability of more advanced procedures, growing need for convenience among consumers, a better understanding of patient’s needs, low-price and finer quality of care are positive contributors of the market.
As per the geographical analysis, the market can be classified into North America (the United States, Canada, and Mexico), Asia Pacific (India, China, Japan, South Korea, Malaysia, Singapore, and the Rest of Asia Pacific), Europe (Germany, United Kingdom, Italy, France, Spain, Netherlands, Belgium, Romania, Russia, and Rest of Europe), Middle East & Africa (Saudi Arabia, United Arab Emirates, and Rest of the Middle East & Africa) and Central & South America (Brazil, Peru, Argentina, and Rest of Central and South America).
The market for North America will be dominant as of 2020 due to the presence of a large number of key market players and medical device manufacturers, increasing number of research and development activities, rising product investments, quick adoption of latest technologies and devices in healthcare setups, presence of adequate reimbursement policies, and growing awareness about the symptoms of such disorders. Moreover favorable government initiatives, increasing healthcare expenditure, advancement in technology, awareness campaigns regarding the benefits of disruptive behavior disorder treatment, presence of skilled professionals, higher adoption among end-user industries, well-developed healthcare sector, the constant launch of advanced products are some of the other factors contributing the growth of this regional market.
However, the Asia Pacific region will grow the fastest due to the rising target population, increasing healthcare management, increasing focus on child healthcare activities, increasing growth opportunities, large scale funding to NGO’s, increasing investment in health infrastructure, awareness of such disorders through social media platforms, rising disposable income, and advancement in technology.
Highland Ridge Hospital, Lakeview Health, Boston Children's Hospital, Springwoods Behavioral Health, Alliance Health Midwest Behavioral Health, INTEGRIS Health, and Jane Phillips Medical Center, Eli Lilly and Company, Bionomics, DURECT Corporation, Chelsea Therapeutics, Johnson & Johnson, and Pfizer, among others, are the major psychiatric treatment healthcare centers competing in the disruptive behavior disorder market.
Please note: This is not an exhaustive list of companies profiled in the report.
Chapter 1 Methodology
1.1 Market Scope & Definitions
1.2 Estimates & Forecast Calculation
1.3 Historical Data Overview and Validation
1.4 Data Sources
1.4.1 Secondary
1.4.2 Primary
Chapter 2 Report Outlook
2.1 Disruptive Behavior Disorder Industry Overview, 2020-2026
2.1.1 Type Overview
2.1.2 Treatment Overview
Chapter 3 Disruptive Behavior Disorder Market Trends
3.1 Market Segmentation
3.2 Industry Background, 2020-2026
3.3 Market Key Trends
3.3.1 Positive Trends
3.3.1.1 The rising prevalence of disruptive behavior disorders
3.3.1.2 The active involvement of NGO’s for better treatment facilities
3.3.2 Industry Challenges
3.3.2.1 The lack of awareness about children’s mental health
3.4 Prospective Growth Scenario
3.4.1 Type Growth Scenario
3.4.2 Treatment Growth Scenario
3.5 COVID-19 Influence over Industry Growth
3.6 Porter’s Analysis
3.7 PESTEL Analysis
3.8 Value Chain & Supply Chain Analysis
3.9 Regulatory Framework
3.9.1 North America
3.9.2 Europe
3.9.3 APAC
3.9.4 LATAM
3.9.5 MEA
3.10 Technology Overview
3.11 Market Share Analysis, 2020
3.11.1 Company Positioning Overview, 2020
Chapter 4 Disruptive Behavior Disorder Market, By Type
4.1 Type Outlook
4.2 Oppositional Defiant Disorder
4.2.1 Market Size, By Region, 2020-2026 (USD Million)
4.3 Conduct Disorder
4.3.1 Market Size, By Region, 2020-2026 (USD Million)
4.4 Intermittent Explosive Disorder
4.4.1 Market Size, By Region, 2020-2026 (USD Million)
Chapter 5 Disruptive Behavior Disorder Market, By Treatment
5.1 Treatment Outlook
5.2 Medication Management
5.2.1 Market Size, By Region, 2020-2026 (USD Million)
5.3 Comprehensive Evaluation
5.3.1 Market Size, By Region, 2020-2026 (USD Million)
5.4 Parenting Modification
5.4.1 Market Size, By Region, 2020-2026 (USD Million)
5.5 Group Therapy
5.5.1 Market Size, By Region, 2020-2026 (USD Million)
5.6 Individual Therapy
5.6.1 Market Size, By Region, 2020-2026 (USD Million)
5.7 Social and Emotional Skills Training
5.7.1 Market Size, By Region, 2020-2026 (USD Million)
5.8 Family Therapy
5.8.1 Market Size, By Region, 2020-2026 (USD Million)
Chapter 6 Disruptive Behavior Disorder Market, By Region
6.1 Regional outlook
6.2 North America
6.2.1 Market Size, By Country 2020-2026 (USD Million)
6.2.2 Market Size, By Type, 2020-2026 (USD Million)
6.2.3 Market Size, By Treatment, 2020-2026 (USD Million)
6.2.4 U.S.
6.2.4.1 Market Size, By Type, 2020-2026 (USD Million)
6.2.4.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.2.5 Canada
6.2.5.1 Market Size, By Type, 2020-2026 (USD Million)
6.2.5.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.3 Europe
6.3.1 Market Size, By Country 2020-2026 (USD Million)
6.3.2 Market Size, By Type, 2020-2026 (USD Million)
6.3.3 Market Size, By Treatment, 2020-2026 (USD Million)
6.3.4 Germany
6.3.4.1 Market Size, By Type, 2020-2026 (USD Million)
6.3.4.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.3.5 UK
6.3.5.1 Market Size, By Type, 2020-2026 (USD Million)
6.3.5.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.3.6 France
6.3.6.1 Market Size, By Type, 2020-2026 (USD Million)
6.3.6.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.3.7 Italy
6.3.7.1 Market Size, By Type, 2020-2026 (USD Million)
6.3.7.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.3.8 Spain
6.3.8.1 Market Size, By Type, 2020-2026 (USD Million)
6.3.8.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.3.9 Russia
6.3.9.1 Market Size, By Type, 2020-2026 (USD Million)
6.3.9.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.4 Asia Pacific
6.4.1 Market Size, By Country 2020-2026 (USD Million)
6.4.2 Market Size, By Type, 2020-2026 (USD Million)
6.4.3 Market Size, By Treatment, 2020-2026 (USD Million)
6.4.4 China
6.4.4.1 Market Size, By Type, 2020-2026 (USD Million)
6.4.4.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.4.5 India
6.4.5.1 Market Size, By Type, 2020-2026 (USD Million)
6.4.5.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.4.6 Japan
6.4.6.1 Market Size, By Type, 2020-2026 (USD Million)
6.4.6.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.4.7 Australia
6.4.7.1 Market Size, By Type, 2020-2026 (USD Million)
6.4.7.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.4.8 South Korea
6.4.8.1 Market Size, By Type, 2020-2026 (USD Million)
6.4.8.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.5 Latin America
6.5.1 Market Size, By Country 2020-2026 (USD Million)
6.5.2 Market Size, By Type, 2020-2026 (USD Million)
6.5.3 Market Size, By Treatment, 2020-2026 (USD Million)
6.5.4 Brazil
6.5.4.1 Market Size, By Type, 2020-2026 (USD Million)
6.5.4.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.5.5 Mexico
6.5.5.1 Market Size, By Type, 2020-2026 (USD Million)
6.5.5.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.5.6 Argentina
6.5.6.1 Market Size, By Type, 2020-2026 (USD Million)
6.5.6.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.6 MEA
6.6.1 Market Size, By Country 2020-2026 (USD Million)
6.6.2 Market Size, By Type, 2020-2026 (USD Million)
6.6.3 Market Size, By Treatment, 2020-2026 (USD Million)
6.6.4 Saudi Arabia
6.6.4.1 Market Size, By Type, 2020-2026 (USD Million)
6.6.4.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.6.5 UAE
6.6.5.1 Market Size, By Type, 2020-2026 (USD Million)
6.6.5.2 Market Size, By Treatment, 2020-2026 (USD Million)
6.6.6 South Africa
6.6.6.1 Market Size, By Type, 2020-2026 (USD Million)
6.6.6.2 Market Size, By Treatment, 2020-2026 (USD Million)
Chapter 7 Company Landscape
7.1 Competitive Analysis, 2020
7.2 Highland Ridge Hospital
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Strategic Positioning
7.2.4 InfoGraphic Analysis
7.3 Lakeview Health
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Strategic Positioning
7.3.4 InfoGraphic Analysis
7.4 Boston Children's Hospital
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Strategic Positioning
7.4.4 InfoGraphic Analysis
7.5 Springwoods Behavioral Health
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Strategic Positioning
7.5.4 InfoGraphic Analysis
7.6 Alliance Health Midwest Behavioral Health
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Strategic Positioning
7.6.4 InfoGraphic Analysis
7.7 INTEGRIS Health
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Strategic Positioning
7.7.4 InfoGraphic Analysis
7.8 Jane Phillips Medical Center
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Strategic Positioning
7.8.4 InfoGraphic Analysis
7.9 Eli Lilly and Company
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Strategic Positioning
7.9.4 InfoGraphic Analysis
7.10 Bionomics
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Strategic Positioning
7.10.4 InfoGraphic Analysis
7.11 Johnson & Johnson
7.11.1 Company Overview
7.11.2 Financial Analysis
7.11.3 Strategic Positioning
7.11.4 InfoGraphic Analysis
7.12 Other Companies
7.12.1 Company Overview
7.12.2 Financial Analysis
7.12.3 Strategic Positioning
7.12.4 InfoGraphic Analysis
The Global Disruptive Behavior Disorder Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.
The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Disruptive Behavior Disorder Market.
The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.
Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.
Frequently Asked Questions
Tailor made solutions just for you
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
OUR CLIENTS